Cover Image
市場調查報告書

核子醫學攝影診斷設備:醫療設備的開發平台評估

Nuclear Imaging Equipment - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 633278
出版日期 內容資訊 英文 168 Pages
訂單完成後即時交付
價格
Back to Top
核子醫學攝影診斷設備:醫療設備的開發平台評估 Nuclear Imaging Equipment - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年04月13日 內容資訊: 英文 168 Pages
簡介

本報告提供全球核子醫學攝影診斷設備的市場上主要的開發中產品 (醫療設備) 及其臨床實驗的進展調查,以及產品特性比較分析 (臨床實驗的各進展階段) 再彙整主要企業簡介及代表性產品,近來的市場動靜 (資本交易·事業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 核子醫學攝影診斷設備概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各部門
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 核子醫學攝影診斷設備:各企業現在臨床實驗中的開發中產品

  • 核子醫學攝影診斷設備企業:各臨床實驗階段的開發中產品
  • 核子醫學攝影診斷設備:各臨床實驗階段的開發中產品

第5章 核子醫學攝影診斷設備的企業·產品概要

  • Brain Biosciences Inc
  • ELECTRON Ltd.
  • Emory University
  • EXINI Diagnostics AB
  • FMI Technologies, Inc.
  • GE Healthcare LLC
  • General De Equipment for Medical Imaging SA
  • IntraMedical Imaging LLC
  • Jagiellonian University
  • Lightpoint Medical Ltd
  • Memorial Sloan Kettering Cancer Center
  • Molecular Dynamics
  • Philips Healthcare
  • PulmoScience, Inc.
  • Ray Vision Intl Corp.
  • Siemens AG
  • Siemens Healthcare GmbH
  • Stanford University
  • Symetrica Security Ltd
  • SynchroPET
  • University of Arizona
  • University of British Columbia
  • University of California Davis
  • University of the Witwatersrand
  • University of Washington
  • West Virginia University
  • Zecotek Photonics Inc
  • Zumatek Inc

第6章 核子醫學攝影診斷設備市場:目前的趨勢

第7章 附錄

目錄
Product Code: GDME0537EPD

GlobalData's Medical Devices sector report, "Nuclear Imaging Equipment - Medical Devices Pipeline Assessment, 2018" provides an overview of Nuclear Imaging Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nuclear Imaging Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nuclear Imaging Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nuclear Imaging Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nuclear Imaging Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 9

2 Introduction 10

  • 2.1 Nuclear Imaging Equipment Overview 10

3 Products under Development 11

  • 3.1 Nuclear Imaging Equipment - Pipeline Products by Stage of Development 11
  • 3.2 Nuclear Imaging Equipment - Pipeline Products by Segment 12
  • 3.3 Nuclear Imaging Equipment - Pipeline Products by Territory 13
  • 3.4 Nuclear Imaging Equipment - Pipeline Products by Regulatory Path 14
  • 3.5 Nuclear Imaging Equipment - Pipeline Products by Estimated Approval Date 15
  • 3.6 Nuclear Imaging Equipment - Ongoing Clinical Trials 16

4 Nuclear Imaging Equipment - Pipeline Products under Development by Companies 17

  • 4.1 Nuclear Imaging Equipment Companies - Pipeline Products by Stage of Development 17
  • 4.2 Nuclear Imaging Equipment - Pipeline Products by Stage of Development 18

5 Nuclear Imaging Equipment Companies and Product Overview 20

  • 5.1 Brain Biosciences Inc Company Overview 20
    • 5.1.1 Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.2 ELECTRON Ltd. Company Overview 22
    • 5.2.1 ELECTRON Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.3 Emory University Company Overview 23
    • 5.3.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 23
  • 5.4 EXINI Diagnostics AB Company Overview 24
    • 5.4.1 EXINI Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 24
  • 5.5 FMI Technologies, Inc. Company Overview 25
    • 5.5.1 FMI Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
  • 5.6 GE Healthcare LLC Company Overview 27
    • 5.6.1 GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 27
  • 5.7 General De Equipment for Medical Imaging SA Company Overview 29
    • 5.7.1 General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.8 IntraMedical Imaging LLC Company Overview 30
    • 5.8.1 IntraMedical Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.9 Jagiellonian University Company Overview 31
    • 5.9.1 Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.10 Lightpoint Medical Ltd Company Overview 32
    • 5.10.1 Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.11 Memorial Sloan Kettering Cancer Center Company Overview 33
    • 5.11.1 Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.12 Molecular Dynamics Company Overview 34
    • 5.12.1 Molecular Dynamics Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.13 Philips Healthcare Company Overview 37
    • 5.13.1 Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.14 PulmoScience, Inc. Company Overview 38
    • 5.14.1 PulmoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.15 Ray Vision Intl Corp. Company Overview 39
    • 5.15.1 Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.16 Siemens AG Company Overview 40
    • 5.16.1 Siemens AG Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.17 Siemens Healthcare GmbH Company Overview 41
    • 5.17.1 Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.18 Stanford University Company Overview 43
    • 5.18.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 43
  • 5.19 Symetrica Security Ltd Company Overview 47
    • 5.19.1 Symetrica Security Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.20 SynchroPET Company Overview 48
    • 5.20.1 SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.21 University of Arizona Company Overview 50
    • 5.21.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.22 University of British Columbia Company Overview 51
    • 5.22.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 51
  • 5.23 University of California Davis Company Overview 52
    • 5.23.1 University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.24 University of the Witwatersrand Company Overview 54
    • 5.24.1 University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.25 University of Washington Company Overview 55
    • 5.25.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.26 West Virginia University Company Overview 58
    • 5.26.1 West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 58
  • 5.27 Zecotek Photonics Inc Company Overview 59
    • 5.27.1 Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.28 Zumatek Inc Company Overview 60
    • 5.28.1 Zumatek Inc Pipeline Products & Ongoing Clinical Trials Overview 60

6 Nuclear Imaging Equipment- Recent Developments 62

  • 6.1 Mar 19, 2018: Philips convenes the 2018 Annual General Meeting of Shareholders 62
  • 6.2 Mar 12, 2018: Zecotek Introduces Innovative Wireless ASIC Microchip For Positron Emission Tomography Medical Imaging 62
  • 6.3 Mar 12, 2018: Testing for Calcium in the Coronary Arteries Provides a Better Way to Predict Heart Attack Events than Stress Testing Alone, News Study Finds 63
  • 6.4 Mar 08, 2018: Navidea Biopharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results 64
  • 6.5 Mar 07, 2018: Philips again ranks first in 'medical technology' patents filed at the European Patent Office 66
  • 6.6 Mar 06, 2018: Agfa HealthCare and Hitachi Healthcare Americas Will Cover Full Imaging Portfolio at AAOS 2018 Booth 66
  • 6.7 Mar 05, 2018: Novel PET Imaging Agent Targets Copper in Tumors, Allowing Early Detection of Prostate Cancer Recurrence 67
  • 6.8 Mar 02, 2018: Canon Medical Systems Expands Aplio Line Up With New A Series 68
  • 6.9 Feb 27, 2018: Lantheus Holdings Names Gary Pruden, Kenneth Pucel and Dr. James Thrall to its Board of Directors 68
  • 6.10 Feb 23, 2018: Digirad Reports Financial Results for the Fourth Quarter Ended December 31, 2017 69
  • 6.11 Feb 20, 2018: Philips increases Green Revenues to EUR 10.7 billion, 60% of total sales in 2017 70
  • 6.12 Feb 13, 2018: SNMMI and ASNC Issue Joint Guidelines for Quantification of Myocardial Blood Flow Using PET 70
  • 6.13 Feb 07, 2018: Pancreatic cancer patients should be offered early scans to avoid unnecessary surgery, says NICE 71
  • 6.14 Feb 06, 2018: AC Immune to Participate in Two Investor Conferences and Provide Scientific Updates at AAT-AD/PD Conference 72
  • 6.15 Feb 02, 2018: Watson Health Continues Winning Streak with 2018 KLAS Awards 73
  • 6.16 Feb 01, 2018: Siemens Appoints New Middle East Finance Head 74
  • 6.17 Jan 31, 2018: Earnings Release and Financial Results Q1 FY 2018 Siemens AG 75
  • 6.18 Jan 31, 2018: Siemens: Jim Hagemann Snabe elected new Supervisory Board Chairman 78
  • 6.19 Jan 31, 2018: Siemens: Earnings Release and Financial Results Q1 FY 2018: Strong order growth highlights successful first quarter 79
  • 6.20 Jan 31, 2018: Siemens Names Jim Hagemann Snabe as new Supervisory Board Chairman 80
  • 6.21 Jan 30, 2018: Philips' Fourth Quarter and Annual Results 2017 81
  • 6.22 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 84
  • 6.23 Jan 17, 2018: NNSA collaborates with global healthcare company to complete conversion of Mo-99 production to LEU-based process 85
  • 6.24 Jan 16, 2018: Oncovision, Enhancing Precision Medicine at RSNA'17 85
  • 6.25 Jan 16, 2018: Siemens Healthineers lays out strategy to bolster market leadership beyond 2025 86
  • 6.26 Jan 11, 2018: Andover will lose nearly 2,000 jobs with Philips move 88
  • 6.27 Jan 04, 2018: SNMMI Publishes Appropriate Use Criteria for Somatostatin Receptor PET Imaging 88
  • 6.28 Jan 03, 2018: Total-Body PET: Maximizing Sensitivity for Clinical Research and Patient Care 89
  • 6.29 Jan 02, 2018: State-of-the-art MRI technology bypasses need for biopsy 90

7 Appendix 165

  • 7.1 Methodology 165
  • 7.2 About GlobalData 168
  • 7.3 Contact Us 168
  • 7.4 Disclaimer 168

List of Tables

1.1 List of Tables

  • Table 1: Nuclear Imaging Equipment - Pipeline Products by Stage of Development 11
  • Table 2: Nuclear Imaging Equipment - Pipeline Products by Segment 12
  • Table 3: Nuclear Imaging Equipment - Pipeline Products by Territory 13
  • Table 4: Nuclear Imaging Equipment - Pipeline Products by Regulatory Path 14
  • Table 5: Nuclear Imaging Equipment - Pipeline Products by Estimated Approval Date 15
  • Table 6: Nuclear Imaging Equipment - Ongoing Clinical Trials 16
  • Table 7: Nuclear Imaging Equipment Companies - Pipeline Products by Stage of Development 17
  • Table 8: Nuclear Imaging Equipment - Pipeline Products by Stage of Development 18
  • Table 9: Brain Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 10: CerePET - Product Status 20
  • Table 11: CerePET - Product Description 20
  • Table 12: FREEMotion - Product Status 21
  • Table 13: FREEMotion - Product Description 21
  • Table 14: ELECTRON Ltd. Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 15: Complex Isotope Diagnostics Device - Product Status 22
  • Table 16: Complex Isotope Diagnostics Device - Product Description 22
  • Table 17: Emory University Pipeline Products & Ongoing Clinical Trials Overview 23
  • Table 18: PET/CT Total Body Scan - Product Status 23
  • Table 19: PET/CT Total Body Scan - Product Description 23
  • Table 20: EXINI Diagnostics AB Pipeline Products & Ongoing Clinical Trials Overview 24
  • Table 21: EXINI PET - Product Status 24
  • Table 22: EXINI PET - Product Description 24
  • Table 23: FMI Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
  • Table 24: ScintiStar Neuro 100 PET/CT/SPECT - Product Status 25
  • Table 25: ScintiStar Neuro 100 PET/CT/SPECT - Product Description 25
  • Table 26: ScintiStar Neuro 200 PET/CT/SPECT - Product Status 26
  • Table 27: ScintiStar Neuro 200 PET/CT/SPECT - Product Description 26
  • Table 28: GE Healthcare LLC Pipeline Products & Ongoing Clinical Trials Overview 27
  • Table 29: Discovery MI - Product Status 27
  • Table 30: Discovery MI - Product Description 27
  • Table 31: Q.Clear - Product Status 28
  • Table 32: Q.Clear - Product Description 28
  • Table 33: General De Equipment for Medical Imaging SA Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 34: CareMiBrain - Product Status 29
  • Table 35: CareMiBrain - Product Description 29
  • Table 36: IntraMedical Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 37: Marginator Beta Camera - Product Status 30
  • Table 38: Marginator Beta Camera - Product Description 30
  • Table 39: Jagiellonian University Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 40: Positron Emission Tomography System - Product Status 31
  • Table 41: Positron Emission Tomography System - Product Description 31
  • Table 42: Lightpoint Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 43: HARLI - Product Status 32
  • Table 44: HARLI - Product Description 32
  • Table 45: Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 46: Micro-NMR System - Product Status 33
  • Table 47: Micro-NMR System - Product Description 33
  • Table 48: Molecular Dynamics Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 49: Valiance X12 - Product Status 34
  • Table 50: Valiance X12 - Product Description 34
  • Table 51: Molecular Dynamics - Ongoing Clinical Trials Overview 35
  • Table 52: Valiance X12 - Molecular Dynamics' Innovative Whole-body CZT Digital SPECT/CT Trial 36
  • Table 53: Philips Healthcare Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 54: Additional PET Scan - Product Status 37
  • Table 55: Additional PET Scan - Product Description 37
  • Table 56: PulmoScience, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 57: PulmoBind - Product Status 38
  • Table 58: PulmoBind - Product Description 38
  • Table 59: Ray Vision Intl Corp. Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 60: Helmet - PET System - Product Status 39
  • Table 61: Helmet - PET System - Product Description 39
  • Table 62: Siemens AG Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 63: Biograph Vision PET/CT System - Product Status 40
  • Table 64: Biograph Vision PET/CT System - Product Description 40
  • Table 65: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 66: xSPECT - Product Status 41
  • Table 67: xSPECT - Product Description 41
  • Table 68: xSPECT Bone - Product Status 42
  • Table 69: xSPECT Bone - Product Description 42
  • Table 70: xSPECT Quantification - Product Status 42
  • Table 71: xSPECT Quantification - Product Description 42
  • Table 72: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 73: Breast-Dedicated PET System - Product Status 43
  • Table 74: Breast-Dedicated PET System - Product Description 43
  • Table 75: Dual Panel PET Scanner - Product Status 44
  • Table 76: Dual Panel PET Scanner - Product Description 44
  • Table 77: Dual-isotope Positron Emitting Tomography System - Product Status 44
  • Table 78: Dual-isotope Positron Emitting Tomography System - Product Description 44
  • Table 79: MR Compatible PET System - Product Status 45
  • Table 80: MR Compatible PET System - Product Description 45
  • Table 81: Next Generation TOF-PET System - Product Status 45
  • Table 82: Next Generation TOF-PET System - Product Description 45
  • Table 83: PET Sensitivity Enhancing Device - Product Status 46
  • Table 84: PET Sensitivity Enhancing Device - Product Description 46
  • Table 85: PET System - Product Status 46
  • Table 86: PET System - Product Description 46
  • Table 87: Symetrica Security Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 88: High Resolution Gamma Camera - Product Status 47
  • Table 89: High Resolution Gamma Camera - Product Description 47
  • Table 90: SynchroPET Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 91: Breast PET-MRI - Product Status 48
  • Table 92: Breast PET-MRI - Product Description 48
  • Table 93: Wrist Scanner - Product Status 48
  • Table 94: Wrist Scanner - Product Description 49
  • Table 95: University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 96: SPECT Imaging Tool - Product Status 50
  • Table 97: SPECT Imaging Tool - Product Description 50
  • Table 98: University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 99: PET Imaging Tool - Product Status 51
  • Table 100: PET Imaging Tool - Product Description 51
  • Table 101: University of California Davis Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 102: Excised Tissue Imager Device - Product Status 52
  • Table 103: Excised Tissue Imager Device - Product Description 52
  • Table 104: EXPLORER - Product Status 53
  • Table 105: EXPLORER - Product Description 53
  • Table 106: University of the Witwatersrand Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 107: Coded Aperture Mask - Product Status 54
  • Table 108: Coded Aperture Mask - Product Description 54
  • Table 109: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 110: DS-PS3 Positron Emission Tomography Detector - Product Status 55
  • Table 111: DS-PS3 Positron Emission Tomography Detector - Product Description 55
  • Table 112: High Resolution PET Detector - Product Status 56
  • Table 113: High Resolution PET Detector - Product Description 56
  • Table 114: PET-Mammogram-Biopsy System - Product Status 56
  • Table 115: PET-Mammogram-Biopsy System - Product Description 57
  • Table 116: West Virginia University Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 117: Positron Emission Tomography (PET) Imager - Product Status 58
  • Table 118: Positron Emission Tomography (PET) Imager - Product Description 58
  • Table 119: Zecotek Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 120: New-Generation PET/MRI Scanning Device - Product Status 59
  • Table 121: New-Generation PET/MRI Scanning Device - Product Description 59
  • Table 122: Zumatek Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 123: PET-CT - Product Status 60
  • Table 124: PET-CT - Product Description 60
  • Table 125: SPECT-CT - Product Status 61
  • Table 126: SPECT-CT - Product Description 61
  • Table 127: Glossary 167

List of Figures

1.2 List of Figures

  • Figure 1: Nuclear Imaging Equipment - Pipeline Products by Stage of Development 11
  • Figure 2: Nuclear Imaging Equipment - Pipeline Products by Segment 12
  • Figure 3: Nuclear Imaging Equipment - Pipeline Products by Territory 13
  • Figure 4: Nuclear Imaging Equipment - Pipeline Products by Regulatory Path 14
  • Figure 5: Nuclear Imaging Equipment - Pipeline Products by Estimated Approval Date 15
  • Figure 6: Nuclear Imaging Equipment - Ongoing Clinical Trials 16
Back to Top